For detox in patients with hepatic dysfunction, which benzodiazepines are preferred?

Enhance your preparation for the PMHNP Certification Exam with Georgette's resources. Delve into multiple-choice questions and detailed explanations to ensure you're ready for success. Boost your study efficiency and exam confidence today!

Multiple Choice

For detox in patients with hepatic dysfunction, which benzodiazepines are preferred?

Explanation:
In detoxification for patients with liver dysfunction, you want benzodiazepines that are cleared without heavily relying on hepatic oxidation and without active metabolites. Lorazepam (Ativan) and oxazepam (Serax) are processed mainly by glucuronidation, a pathway less affected by liver disease, and they have fewer or no active metabolites. This reduces the risk of accumulation and prolonged sedation in hepatic impairment, making them safer choices for detox in this population. In contrast, benzodiazepines like diazepam, alprazolam, and clonazepam rely more on hepatic oxidation and can produce active metabolites that accumulate in liver disease, increasing the risk of oversedation and respiratory depression.

In detoxification for patients with liver dysfunction, you want benzodiazepines that are cleared without heavily relying on hepatic oxidation and without active metabolites. Lorazepam (Ativan) and oxazepam (Serax) are processed mainly by glucuronidation, a pathway less affected by liver disease, and they have fewer or no active metabolites. This reduces the risk of accumulation and prolonged sedation in hepatic impairment, making them safer choices for detox in this population. In contrast, benzodiazepines like diazepam, alprazolam, and clonazepam rely more on hepatic oxidation and can produce active metabolites that accumulate in liver disease, increasing the risk of oversedation and respiratory depression.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy